Chronicle Journal: Finance

Novavax expects FDA clearance for Covid vaccine as early as May, CEO says

The Food and Drug Administration could authorize Novavax's Covid-19 for emergency use as early as May, the company's CEO, Stanley Erck, told CNBC.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.